Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10639	Companies
226163	Keywords
154636	Articles
119683	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 04/20/2026 at 06:30, 2 months 5 days ago

Formycon invites to Conference Call on the Results of the Financial Year 2025 and announces Participation in international Investor Conferences in the 2nd Quarter of 2026
Formycon AG to hold Conference Call on Results of FY 2025 and participate in international Investor Conferences in Q2 2026. Details and registration at provided links

Conference Call Investor Conferences Formycon AG Biosimilars Financial Year 2025
BRIEF

published on 04/15/2026 at 19:57, 2 months 9 days ago

Formycon AG annonce des résultats préliminaires améliorés pour l'exercice 2025.

Formycon AG Fonds De Roulement États Financiers Annuels Exercice Financier 2025 EBITDA Du Groupe
BRIEF

published on 04/15/2026 at 19:57, 2 months 9 days ago

Formycon AG Reports Improved Preliminary Figures for 2025 Fiscal Year

Working Capital Annual Financial Statements Formycon AG 2025 Fiscal Year Group EBITDA
PRESS RELEASE

published on 04/15/2026 at 19:52, 2 months 9 days ago

EQS-Adhoc: Formycon AG:
Formycon AG announces improved preliminary figures for the 2025 fiscal year, including adjusted EBITDA and working capital, with annual financial statements publication set for April 22, 2026

Financial Statements EBITDA Formycon AG Preliminary Figures 2025 Fiscal Year
BRIEF

published on 03/19/2026 at 06:35, 3 months 6 days ago

Formycon obtient l'autorisation de commercialiser un biosimilaire en Europe et au-delà.

Formycon Maladies De La Rétine Expansion Du Marché Licences De Biosimilaires Règlement De Brevet
BRIEF

published on 03/19/2026 at 06:35, 3 months 6 days ago

Formycon Secures Licensing for Biosimilar in Europe and Beyond

Market Expansion Formycon Retinal Diseases Biosimilar Licensing Patent Settlement
PRESS RELEASE

published on 03/19/2026 at 06:30, 3 months 6 days ago

Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer
Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer

Bayer Biosimilar Formycon Regeneron Aflibercept
BRIEF

published on 03/18/2026 at 18:58, 3 months 6 days ago

Formycon AG Delays 2025 Financial Statement Publication

Regulatory Compliance Financial Statement Formycon AG Postponement 2025 Results
BRIEF

published on 03/18/2026 at 18:58, 3 months 6 days ago

Formycon AG reporte la publication de ses états financiers 2025

Formycon AG États Financiers Conformité Réglementaire Report Résultats 2025
PRESS RELEASE

published on 03/18/2026 at 18:53, 3 months 6 days ago

EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025 due to internal system changes, extended reconciliation work, and audit delays

Formycon AG Postponement 2025 Audited Financial Statements Internal System Changes

Accesswire

Published on 06/25/2026 at 13:00, 29 minutes ago

Irving Resources Discovers High-Grade Feeder at Omu Sinter
Published on 06/25/2026 at 13:00, 29 minutes ago

Pivotree Appoints Joel Farquhar to Chief Technology Officer
Published on 06/25/2026 at 12:58, 31 minutes ago

BlackBerry Reports First Quarter Fiscal Year 2027 Results
Published on 06/25/2026 at 12:00, 1 hour 29 minutes ago

Zomedica's Assisi Loop(R) Products Designated "Fear Free(R)" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC
Published on 06/25/2026 at 11:30, 1 hour 59 minutes ago

FireFox Gold Closes Second and Final Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 06/25/2026 at 13:00, 29 minutes ago

Pylontech Unveils PyOcean, a 6.4MWh Energy Storage System Powered by Self-Developed 601Ah Cells
Published on 06/25/2026 at 12:50, 39 minutes ago

MindMaze Therapeutics Announces Results of Annual General Meeting
Published on 06/25/2026 at 12:24, 1 hour 5 minutes ago

EQS-Adhoc: TTL Beteiligungs- und Grundbesitz-AG adjusts schedule for the publication of its 2025 annual and consolidated financial statements to align with Branicks Group AG’s new timeline
Published on 06/25/2026 at 12:23, 1 hour 5 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 06/25/2026 at 12:21, 1 hour 8 minutes ago

Amundi Physical Metals plc: Final Terms

Les Echos

Published on 06/25/2026 at 07:30, 5 hours 59 minutes ago

Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
Published on 06/25/2026 at 07:30, 5 hours 59 minutes ago

Gimv ondertekent een overeenkomst voor de overname van Groupe Cap Vert, de Franse marktleider in multispecialistische essentiële diensten voor het beheer van bomen en groene infrastructuur, van Ambienta.
Published on 06/25/2026 at 07:30, 5 hours 59 minutes ago

Gimv signe un accord en vue d’acquérir le Groupe Cap Vert, leader français multi-spécialiste des services de gestion du patrimoine arboré et végétal, auprès d’Ambienta
Published on 06/24/2026 at 19:00, 18 hours 29 minutes ago

ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %
Published on 06/24/2026 at 18:00, 19 hours 29 minutes ago

Annual Results 2025-26

View all LES ECHOS COMFI WIRE